Mirodenafil
Small moleculeexperimental
Mirodenafil belongs to the drug class PDE5 inhibitors, which includes avanafil, sildenafil, tadalafil, udenafil, and vardenafil, and is the first-line treatment for erectile dysfunction. Developed by SK Chemicals Life Science, mirodenafil is marketed in Korea under the trade name Mvix, offered both as tablets and as orally dissolving films. — Wikipedia
Clinical trial activity
10 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Sep 1, 2004 (NCT00351065)
Timeline
Indications
Mechanism of action
- Phosphodiesterase 5AINHIBITOR
PDE5A inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCCOc1ccc(S(=O)(=O)N2CCN(CCO)CC2)cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1- Mol. weight
- 531.68 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMirodenafil ↗
- ChEMBLCHEMBL4297518 ↗
Also known as
- 2-(5-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)-2-n-propoxyphenyl)-5-ethyl-7-n-propyl-3,5-dihydro-4h-pyrrolo(3,2-d)pyrimidin-4-one dihydrochloride
- 5-ethyl-2-(5-(4-(2-hydroxyethyl)piperazine-1-sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo(3,2-d)pyrimidin-4-one
- mirodenafil
- mirodenafil
- mirodenafil
- mirodenafil
- mirodenafil
- mirodenafil
- mirodenafil dihydrochloride
- mvix
- sk3530
- sk3530
- sk3530
- sk3530
- sk3530.2hcl
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02485041 | Phase 1 | Nov 1, 2014 | Chonbuk National University, SK Chemicals |
| NCT02485028 | Phase 1 | Oct 1, 2013 | SK Chemicals, Sungkyunkwan University |
| NCT01232010 | Phase 1 | Nov 1, 2009 | SK Chemicals, University of Ulsan |
| NCT00626743 | Phase 1 | May 1, 2008 | Inje University, SK Chemicals |
| NCT00644007 | Phase 3 | Dec 1, 2007 | SK Chemicals |
| NCT00705861 | Phase 3 | Nov 1, 2007 | SK Chemicals |
| NCT00489606 | Phase 1 | Apr 1, 2007 | Seoul National University, SK Chemicals |
| NCT00489450 | Phase 1 | Mar 1, 2007 | Seoul National University, SK Chemicals |
| NCT00443625 | Phase 1 | Dec 1, 2006 | Seoul National University, SK Chemicals |
| NCT00351065 | Phase 2 | Sep 1, 2004 | Seoul National University, SK Chemicals |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| SK Chemicals | For profit | 10 | 9 | 3 | 2004 |
| Seoul National University | Academic/Hospital | 4 | 0 | 2 | 2004 |
| Chonbuk National University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Inje University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Sungkyunkwan University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Ulsan | Academic/Hospital | 1 | 1 | 1 | 2009 |
6 organizations
Page 1 / 1